The School of Pharmacy is in the process of establishing a new Pharm.D. program. As part of this process, the School submitted its formal application for pre-candidacy to the Accreditation Council for Pharmacy Education (ACPE) in April 2023. President Darrell K. Williams, Executive VP and Provost JoAnn Haysbert and Dean Anand Iyer met with the ACPE Board of Directors in Chicago in June 2023, and the Board has scheduled an on-site visit in November 2023 to evaluate the program. Based on recommendations from the site visit team, the ACPE Board will make a decision on approval of pre-candidacy in January 2024. If successful, the School will matriculate its new Pharm.D. cohort in the fall of 2024.

As part of our plans for the new program, the School has developed a new Pharm.D. curriculum, is fully renovating its learning facilities (with an expected completion date of July 2024), is developing a new 10-year strategic plan, has implemented a strong faculty and staff hiring plan, and is continuing to develop and implement many other aspects of the new program. The University and School’s administration, faculty and staff are working diligently to ensure that all programmatic aspects are developed to meet the 25 standards set forth by the ACPE.

When the School of Pharmacy receives approval of pre-candidacy status, the new Pharm.D. curriculum will be implemented. This curriculum has already been fully approved by School and University committees.

3.19.20 – COVID – 19 Update from the Office of Experiential Education

3.13.20 – Office of Experiential Education COVID – 19 Response 

3.11.20 – HUSOP COVID – 19 Letter from the Dean

January 2018 Explanatory Statement

July 2017 Explanatory Statement